Main > RHEUMATOLOGY>RHEUMATOID ARTHRITIS > Treatment > DHODH Inhibitors (Vidofludimus) > Co.: DE. 4. Phase IIB
Co.: DE. 4. Phase IIB's subsections
Company
DHODH: DiHydroOrotate DeHydrogenase
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 01.22.2013
UpDate: 11.07.2011
Co.: DE. 4. Phase IIB's products
This section has no products